AREV Financial Statements From 2010 to 2025
| AREVF Stock | USD 0.0005 0.00 0.00% |
Check AREV NanoTec financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AREV NanoTec's main balance sheet or income statement drivers, such as , as well as many indicators such as . AREV financial statements analysis is a perfect complement when working with AREV NanoTec Valuation or Volatility modules.
AREV |
AREV NanoTec Brands Company Shares Outstanding Analysis
AREV NanoTec's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current AREV NanoTec Shares Outstanding | 31.54 M |
Most of AREV NanoTec's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AREV NanoTec Brands is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, AREV NanoTec Brands has 31.54 M of shares currently outstending. This is 82.53% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 94.48% higher than that of the company.
AREV NanoTec Brands Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AREV NanoTec's current stock value. Our valuation model uses many indicators to compare AREV NanoTec value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AREV NanoTec competition to find correlations between indicators driving AREV NanoTec's intrinsic value. More Info.AREV NanoTec Brands is rated second in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AREV NanoTec's earnings, one of the primary drivers of an investment's value.About AREV NanoTec Financial Statements
AREV NanoTec stakeholders use historical fundamental indicators, such as AREV NanoTec's revenue or net income, to determine how well the company is positioned to perform in the future. Although AREV NanoTec investors may analyze each financial statement separately, they are all interrelated. For example, changes in AREV NanoTec's assets and liabilities are reflected in the revenues and expenses on AREV NanoTec's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AREV NanoTec Brands. Please read more on our technical analysis and fundamental analysis pages.
AREV Life Sciences Global Corp., an integrated life science discovery company, produces and sells functional ingredients in Canada. AREV Life Sciences Global Corp. was incorporated in 2005 and is based in Coquitlam, Canada. Arev Life is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in AREV Pink Sheet
AREV NanoTec financial ratios help investors to determine whether AREV Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AREV with respect to the benefits of owning AREV NanoTec security.